CARsgen Therapeutics Holdings Limited
CRTHF
$0.76
$0.01351.81%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 704.89% | 693.45% | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 704.89% | 693.45% | -- | -- | -- |
| Cost of Revenue | 357.84% | 351.29% | -- | -- | -- |
| Gross Profit | 1,719.71% | 1,692.98% | -- | -- | -- |
| SG&A Expenses | -53.85% | -54.52% | 5.19% | 6.03% | 37.04% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 107.89% | 107.77% | 5,366.43% | 5,411.12% | 75.60% |
| Total Operating Expenses | -42.53% | -43.35% | 11.69% | 12.58% | -13.60% |
| Operating Income | 56.97% | 57.59% | -3.60% | -4.43% | 15.24% |
| Income Before Tax | 78.50% | 78.81% | -30.61% | -31.66% | 15.90% |
| Income Tax Expenses | -- | -- | -14.54% | -13.88% | -- |
| Earnings from Continuing Operations | 78.50% | 78.81% | -30.56% | -31.60% | 15.90% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 78.50% | 78.81% | -30.56% | -31.60% | 15.90% |
| EBIT | 56.97% | 57.59% | -3.60% | -4.43% | 15.24% |
| EBITDA | 62.87% | 63.40% | -4.81% | -5.65% | 16.81% |
| EPS Basic | 78.21% | 78.64% | -32.55% | -33.33% | 16.15% |
| Normalized Basic EPS | 78.31% | 78.55% | -32.21% | -33.46% | 16.31% |
| EPS Diluted | 78.21% | 78.64% | -32.55% | -33.33% | 16.15% |
| Normalized Diluted EPS | 78.31% | 78.55% | -32.21% | -33.46% | 16.31% |
| Average Basic Shares Outstanding | -1.01% | -1.01% | -1.45% | -1.45% | 0.28% |
| Average Diluted Shares Outstanding | -1.01% | -1.01% | -1.45% | -1.45% | 0.28% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |